Volpe Alessandro, Panzarella Tony, Rendon Ricardo A, Haider Masoom A, Kondylis Filippos I, Jewett Michael A S
Division of Urology, Department of Surgical Oncology, University Health Network (Princess Margaret Hospital), University of Toronto, Toronto, Ontario, Canada.
Cancer. 2004 Feb 15;100(4):738-45. doi: 10.1002/cncr.20025.
The incidence of renal cell carcinoma (RCC) is increasing, largely due to the widespread use of cross-sectional imaging. Most renal tumors are detected incidentally as small, asymptomatic masses. To study their natural history, the authors prospectively followed a series of patients with this type of lesion who were unsuited for or refused surgery.
Twenty-nine patients with 32 masses that measured < 4 cm in greatest dimension (25 solid masses and 7 complex cystic masses) were studied. The primary outcome was tumor size, which was calculated as volume over time. All patients were followed with serial abdominal imaging, and each mass had at least three follow-up measurements. The median follow-up was 27.9 months (range, 5.3-143.0 months).
Overall, the average growth rate did not differ statistically from zero growth (P = 0.09; 95% confidence interval, - 0.005-0.2 cm per year) and was not associated with either initial size (P = 0.28) or mass type (P = 0.41). Seven masses (22%) reached 4 cm in greatest dimension after 12-85 months of follow-up. Eight masses (25%) doubled their volumes within 12 months. Overall, 11 masses (34%) fulfilled 1 of these 2 criteria of rapid growth. Nine tumors were removed surgically after an average of 3.1 years of follow-up because it was believed that they were growing fast. No patient had disease progression.
Approximately one-third of small renal masses that are presumed RCCs grow if they are managed conservatively and are followed with serial imaging. The growth rate is slow or undetectable in the majority of patients. These observations raise the possibility of a period of initial observation in selected patients, particularly the elderly or infirm.
肾细胞癌(RCC)的发病率正在上升,这主要归因于横断面成像技术的广泛应用。大多数肾肿瘤是在偶然情况下被发现的,表现为小的、无症状的肿块。为了研究它们的自然病史,作者对一系列不适合手术或拒绝手术的此类病变患者进行了前瞻性随访。
对29例患者的32个最大直径小于4 cm的肿块(25个实性肿块和7个复杂性囊性肿块)进行了研究。主要观察指标是肿瘤大小,通过随时间变化的体积来计算。所有患者均接受腹部系列成像检查,每个肿块至少有三次随访测量。中位随访时间为27.9个月(范围为5.3 - 143.0个月)。
总体而言,平均生长速率与零生长在统计学上无差异(P = 0.09;95%置信区间为每年 - 0.005 - 0.2 cm),且与初始大小(P = 0.28)或肿块类型(P = 0.41)均无关。在12 - 85个月的随访后,7个肿块(22%)最大直径达到4 cm。8个肿块(25%)在12个月内体积翻倍。总体而言,11个肿块(34%)满足这两个快速生长标准中的1个。在平均随访3.1年后,9个肿瘤因被认为生长迅速而接受了手术切除。没有患者出现疾病进展。
如果对疑似肾细胞癌的小肾肿块进行保守治疗并通过系列成像进行随访,大约三分之一的肿块会生长。大多数患者的生长速率缓慢或难以检测到。这些观察结果增加了对部分患者,尤其是老年或体弱患者进行初始观察期的可能性。